Kobayashi, T.; Nakamura, Y.; Suzuki, T.; Yamaguchi, T.; Takeda, R.; Takagi, M.; Hasegawa, T.; Kosho, T.; Kato, H.
Efficacy and Safety of Denosumab Therapy for Osteogenesis Imperfecta Patients with Osteoporosis—Case Series. J. Clin. Med. 2018, 7, 479.
https://doi.org/10.3390/jcm7120479
AMA Style
Kobayashi T, Nakamura Y, Suzuki T, Yamaguchi T, Takeda R, Takagi M, Hasegawa T, Kosho T, Kato H.
Efficacy and Safety of Denosumab Therapy for Osteogenesis Imperfecta Patients with Osteoporosis—Case Series. Journal of Clinical Medicine. 2018; 7(12):479.
https://doi.org/10.3390/jcm7120479
Chicago/Turabian Style
Kobayashi, Tsukasa, Yukio Nakamura, Takako Suzuki, Tomomi Yamaguchi, Ryojun Takeda, Masaki Takagi, Tomonobu Hasegawa, Tomoki Kosho, and Hiroyuki Kato.
2018. "Efficacy and Safety of Denosumab Therapy for Osteogenesis Imperfecta Patients with Osteoporosis—Case Series" Journal of Clinical Medicine 7, no. 12: 479.
https://doi.org/10.3390/jcm7120479
APA Style
Kobayashi, T., Nakamura, Y., Suzuki, T., Yamaguchi, T., Takeda, R., Takagi, M., Hasegawa, T., Kosho, T., & Kato, H.
(2018). Efficacy and Safety of Denosumab Therapy for Osteogenesis Imperfecta Patients with Osteoporosis—Case Series. Journal of Clinical Medicine, 7(12), 479.
https://doi.org/10.3390/jcm7120479